These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical and laboratory changes produced by piroxicam in rheumatoid arthritis. De Zubiria RC; Charria A; Lobo Guerrero D Eur J Rheumatol Inflamm; 1983; 6(1):56-62. PubMed ID: 6861814 [TBL] [Abstract][Full Text] [Related]
5. Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs young adults. Darragh A; Gordon AJ; O'Byrne H; Hobbs D; Casey E Eur J Clin Pharmacol; 1985; 28(3):305-9. PubMed ID: 4007035 [TBL] [Abstract][Full Text] [Related]
6. Piroxicam--a literature review of new results from laboratory and clinical studies. Ando GA; Lombardino JG Eur J Rheumatol Inflamm; 1983; 6(1):3-23. PubMed ID: 6345166 [TBL] [Abstract][Full Text] [Related]
7. Piroxicam suppositories for osteoarthritis and rheumatoid arthritis: an open multicentre study in 116 patients. Heynen G; Dessain P Eur J Rheumatol Inflamm; 1983; 6(1):134-8. PubMed ID: 6345164 [TBL] [Abstract][Full Text] [Related]
8. [Onset of effect of isoxicam and piroxicam. A double-blind parallel study]. Bara S; Wagenhäuser FJ Fortschr Med; 1985 Jan; 103(4):73-6. PubMed ID: 3972324 [No Abstract] [Full Text] [Related]
9. Pharmacokinetics of piroxicam in man. Hobbs DC Eur J Rheumatol Inflamm; 1983; 6(1):46-55. PubMed ID: 6861813 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of piroxicam and indomethacin retard in osteoarthritis. Muller-Fassbender HH; Nagel E Eur J Rheumatol Inflamm; 1983; 6(1):106-12. PubMed ID: 6861809 [TBL] [Abstract][Full Text] [Related]
11. [Clinical pharmacology of oxicams]. Stochla K; Rewerski W Pol Tyg Lek; 1983 Jul; 38(30):933-7. PubMed ID: 6657533 [No Abstract] [Full Text] [Related]
12. Piroxicam capsules versus suppositories: a pharmacokinetic and clinical trial. Aärynen M; Palho J Arzneimittelforschung; 1986 Apr; 36(4):744-7. PubMed ID: 3521618 [TBL] [Abstract][Full Text] [Related]
13. [Relation between clinical response and plasma and synovial fluid levels of piroxicam]. Chérié Lignière G Clin Ter; 1984 Feb; 108(4):297-304. PubMed ID: 6232066 [No Abstract] [Full Text] [Related]
14. Pain relief in relation to tissue piroxicam concentrations in hip osteoarthritis. Julkunen H; Michelsson JE; Mattila MJ Ann Clin Res; 1983 Jun; 15(3):99-103. PubMed ID: 6605710 [TBL] [Abstract][Full Text] [Related]
16. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis. Domljan Z; Durrigl T Eur J Rheumatol Inflamm; 1983; 6(3):291-6. PubMed ID: 6391934 [TBL] [Abstract][Full Text] [Related]
17. Effect of impairment of renal function on the accumulation and disposition of isoxicam. Bury RW; Whitworth JA; Saines D; Kincaid-Smith P; Moulds RF Eur J Clin Pharmacol; 1985; 28(5):585-8. PubMed ID: 4043201 [TBL] [Abstract][Full Text] [Related]
18. A multi-centre study of piroxicam in the treatment of osteoarthritis and rheumatoid arthritis in general practice. Gow PJ Curr Med Res Opin; 1983; 8(9):618-21. PubMed ID: 6607820 [TBL] [Abstract][Full Text] [Related]
19. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis. Trnavská Z; Trnavský K; Zlnay D Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the efficacy and tolerance of a new non-steroidal anti-inflammatory agent, isoxicam]. Marcolongo R; Giordano N; Fioravanti A; Frati E; Mariani AM; Casini A Clin Ter; 1984 Dec; 111(6):513-9. PubMed ID: 6525811 [No Abstract] [Full Text] [Related] [Next] [New Search]